Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629-Reference-Cited by-同舟云学术

Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629

Published:2023-11-09 Issue:12 Volume:13 Page:3165-3180
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Bratland Åse,Munoz-Couselo Eva^ORCID,Mortier Laurent,Roshdy Osama,González Rene,Schachter Jacob,Arance Ana M.,Grange Florent,Meyer Nicolas,Joshi Abhishek Jagdish^ORCID,Billan Salem,Hughes Brett G. M.^ORCID,Grob Jean-Jacques,Ramakrishnan Karthik,Ge Joy,Gumuscu Burak,Swaby Ramona F.,Gutzmer Ralf^ORCID

Funder

Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-023-01059-y.pdf

Reference24 articles.

1. Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018;78(2):237–47.

2. Fania L, Didona D, Di Pietro FR, Verkhovskaia S, Morese R, Paolino G, et al. Cutaneous squamous cell carcinoma: From pathophysiology to novel therapeutic approaches. Biomedicines. 2021;9(2):171.

3. Ciążyńska M, Kamińska-Winciorek G, Lange D, Lewandowski B, Reich A, Sławińska M, et al. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep. 2021;11(1):4337.

4. Stang A, Khil L, Kajüter H, Pandeya N, Schmults CD, Ruiz ES, et al. Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents. J Eur Acad Dermatol Venereol. 2019;33(suppl 8):6–10.

5. Petersen ET, Ahmed SR, Chen L, Silapunt S, Migden MR. Review of systemic agents in the treatment of advanced cutaneous squamous cell carcinoma. Future Oncol. 2019;15(27):3171–84.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy For US Patients With Metastatic Cancer at the End of Life;JAMA Oncology;2024-08-01